This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Shionogi Company Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Natsuko Kojima: Innovator in Pharmaceutical Composition
Introduction
Natsuko Kojima is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for medical use. Her innovative work has led to the creation of a patent that addresses important aspects of pharmaceutical stability.
Latest Patents
Natsuko Kojima holds a patent for a preparation containing cephalosporin having a catechol moiety. The patent describes a stable pharmaceutical composition that includes a compound represented by a specific formula, its pharmaceutically acceptable salt, or a solvate thereof. The composition is designed to be prepared using a combination of ingredients, including alkali metal chlorides, alkaline earth metal chlorides, transition metal chlorides, magnesium chloride, and sugar or sugar alcohol. This invention is crucial for enhancing the stability and efficacy of pharmaceutical products.
Career Highlights
Throughout her career, Natsuko has been associated with Shionogi Company Limited, a well-respected organization in the pharmaceutical industry. Her work has not only contributed to the company's portfolio but has also advanced the field of pharmaceutical sciences. Natsuko's dedication to research and innovation has positioned her as a key figure in her area of expertise.
Collaborations
Natsuko Kojima has collaborated with notable colleagues, including Fumihiko Matsubara and Nao Matsuoka. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research and development within the company.
Conclusion
Natsuko Kojima's contributions to pharmaceutical innovation exemplify the impact of dedicated research and development in the medical field. Her patent for a stable pharmaceutical composition highlights her commitment to improving healthcare solutions. Through her work at Shionogi Company Limited, she continues to influence the future of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
